Literature DB >> 30217480

Magnetic Resonance-guided Radiotherapy - Can We Justify More Expensive Technology?

A C Tree1, R Huddart1, A Choudhury2.   

Abstract

Entities:  

Year:  2018        PMID： 30217480     DOI： 10.1016/j.clon.2018.08.013

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN： 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  3 in total

1.  Implementation of Magnetic Resonance Imaging-Guided Radiation Therapy in Routine Care: Opportunities and Challenges in the United States.

Authors:  Charisma Hehakaya; Ankur M Sharma; Jochem R N van der Voort Van Zijp; Diederick E Grobbee; Helena M Verkooijen; Enrique W Izaguirre; Ellen H M Moors
Journal:  Adv Radiat Oncol       Date:  2022-05-25

Review 2.  A narrative review of MRI acquisition for MR-guided-radiotherapy in prostate cancer.

Authors:  Jing Yuan; Darren M C Poon; Gladys Lo; Oi Lei Wong; Kin Yin Cheung; Siu Ki Yu
Journal:  Quant Imaging Med Surg       Date:  2022-02

3.  Variations in Demand across England for the Magnetic Resonance-Linac Technology, Simulated Utilising Local-level Demographic and Cancer Data in the Malthus Project.

Authors:  T Mee; A J Vickers; R Jena; K J Kirkby; A Choudhury; N F Kirkby
Journal:  Clin Oncol (R Coll Radiol)       Date:  2021-03-26       Impact factor: 4.925
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.